About this trial
This is a retrospective, hospital-based and multi-center study aiming at investigating the potential exposures associated with the formation, progression, and rupture of intracranial aneurysms in Chinese population.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
IA diagnosis (ruptured or unruptured) or exclusion by digital subtractive angiography (DSA) or by cranial computed tomography angiography (CTA) / magnetic resonance angiography (MRA);
Aged ≥ 18 and ≤ 18 years old;
With complete demographic data including age and sex;
With medical record archiving officially.
Disqualifiers
Missing data of age, sex or hypertensive status;
Age <18 or >80 years;
Pregnancy;
With a history of intracranial arteriovenous malformation, Moyamoya, polycystic kidney disease, Ehlers-Danlos syndrome, Gronblad-Strandberg syndrome, or Marfan syndrome;
Trial population
The study population underwent cerebrovascular examinations, with the majority conducted in clinical settings and the minority for health screening purposes, sourced from real-world electronic medical record databases.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Intracranial aneurysm
The presence or absence of IAs detected by digital subtractive angiography or by cranial computed tomography angiography / magnetic resonance angiography.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Zhujiang Hospital
Lead sponsor
Beijing Tiantan Hospital
Collaborator
Guangdong Provincial People's Hospital
Collaborator
First Affiliated Hospital of Chongqing Medical University
Collaborator
The Affiliated Hospital Of Southwest Medical University
Collaborator